BRD2 and Hypergonadotropic hypogonadism: The drug reduced luteinizing hormone (LH) in females with polycystic ovary syndrome [6], follicle-stimulating hormone (FSH) in women after menopause [7], and both FSH and LH in males with hypergonadotropic hypogonadism [8].